Cargando…

Molecular peanut sensitization patterns in Lithuanian children with suspected allergic symptoms

INTRODUCTION: There are no in-depth studies describing the peanut sensitization molecular patterns in Lithuanian children. AIM: To investigate the age-related patterns of molecular peanut sensitization profiles in Lithuanian children with suspected allergic symptoms. MATERIAL AND METHODS: We perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Adomaite, Ieva, Gorbikova, Evelina, Miskinyte, Monika, Eidukaite, Audrone, Miskiniene, Asta, Rudzeviciene, Odilija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993191/
https://www.ncbi.nlm.nih.gov/pubmed/36909918
http://dx.doi.org/10.5114/ada.2022.124741
_version_ 1784902477507723264
author Adomaite, Ieva
Gorbikova, Evelina
Miskinyte, Monika
Eidukaite, Audrone
Miskiniene, Asta
Rudzeviciene, Odilija
author_facet Adomaite, Ieva
Gorbikova, Evelina
Miskinyte, Monika
Eidukaite, Audrone
Miskiniene, Asta
Rudzeviciene, Odilija
author_sort Adomaite, Ieva
collection PubMed
description INTRODUCTION: There are no in-depth studies describing the peanut sensitization molecular patterns in Lithuanian children. AIM: To investigate the age-related patterns of molecular peanut sensitization profiles in Lithuanian children with suspected allergic symptoms. MATERIAL AND METHODS: We performed a retrospective analysis of peanut sensitization profiles in 576 Lithuanian children with possible allergic symptoms. Patient data were categorized according to age groups: 0–2, 3–6, 7–12, and 13–18 years. Specific immunoglobulin E levels to peanut molecular components: Ara h 1, Ara h 2, Ara h 3, Ara h 6, Ara h 8, Ara h 9, Ara h 15, and birch major allergen component Bet v 1 were analyzed. RESULTS: Sensitization to at least one peanut protein was observed in 148 (25.7%) children. In children aged ≤ 2 years, most children were sensitized to Ara h 1 – 11 (12.1%). In children aged from 3 to 6 years, the sensitization to Ara h 1 remained the most prevalent in 40 (16.6%) children. The most prevalent sensitization in children aged from 7 to 12 years was to Ara h 8 in 39 (24.5%) of them. In children aged ≥ 13 years, Ara h 8 remained the most prevalent sensitizer in 21 (24.7%) of them. CONCLUSIONS: One-fourth of children with suspected allergic symptoms are sensitized to at least one peanut molecular component in Lithuania. Infants and preschool children are most commonly sensitized to seed storage proteins, while school-age children to Ara h 8 allergen.
format Online
Article
Text
id pubmed-9993191
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-99931912023-03-09 Molecular peanut sensitization patterns in Lithuanian children with suspected allergic symptoms Adomaite, Ieva Gorbikova, Evelina Miskinyte, Monika Eidukaite, Audrone Miskiniene, Asta Rudzeviciene, Odilija Postepy Dermatol Alergol Original Paper INTRODUCTION: There are no in-depth studies describing the peanut sensitization molecular patterns in Lithuanian children. AIM: To investigate the age-related patterns of molecular peanut sensitization profiles in Lithuanian children with suspected allergic symptoms. MATERIAL AND METHODS: We performed a retrospective analysis of peanut sensitization profiles in 576 Lithuanian children with possible allergic symptoms. Patient data were categorized according to age groups: 0–2, 3–6, 7–12, and 13–18 years. Specific immunoglobulin E levels to peanut molecular components: Ara h 1, Ara h 2, Ara h 3, Ara h 6, Ara h 8, Ara h 9, Ara h 15, and birch major allergen component Bet v 1 were analyzed. RESULTS: Sensitization to at least one peanut protein was observed in 148 (25.7%) children. In children aged ≤ 2 years, most children were sensitized to Ara h 1 – 11 (12.1%). In children aged from 3 to 6 years, the sensitization to Ara h 1 remained the most prevalent in 40 (16.6%) children. The most prevalent sensitization in children aged from 7 to 12 years was to Ara h 8 in 39 (24.5%) of them. In children aged ≥ 13 years, Ara h 8 remained the most prevalent sensitizer in 21 (24.7%) of them. CONCLUSIONS: One-fourth of children with suspected allergic symptoms are sensitized to at least one peanut molecular component in Lithuania. Infants and preschool children are most commonly sensitized to seed storage proteins, while school-age children to Ara h 8 allergen. Termedia Publishing House 2023-02-27 2023-02 /pmc/articles/PMC9993191/ /pubmed/36909918 http://dx.doi.org/10.5114/ada.2022.124741 Text en Copyright: © 2023 Termedia Sp. z o. o. https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Adomaite, Ieva
Gorbikova, Evelina
Miskinyte, Monika
Eidukaite, Audrone
Miskiniene, Asta
Rudzeviciene, Odilija
Molecular peanut sensitization patterns in Lithuanian children with suspected allergic symptoms
title Molecular peanut sensitization patterns in Lithuanian children with suspected allergic symptoms
title_full Molecular peanut sensitization patterns in Lithuanian children with suspected allergic symptoms
title_fullStr Molecular peanut sensitization patterns in Lithuanian children with suspected allergic symptoms
title_full_unstemmed Molecular peanut sensitization patterns in Lithuanian children with suspected allergic symptoms
title_short Molecular peanut sensitization patterns in Lithuanian children with suspected allergic symptoms
title_sort molecular peanut sensitization patterns in lithuanian children with suspected allergic symptoms
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993191/
https://www.ncbi.nlm.nih.gov/pubmed/36909918
http://dx.doi.org/10.5114/ada.2022.124741
work_keys_str_mv AT adomaiteieva molecularpeanutsensitizationpatternsinlithuanianchildrenwithsuspectedallergicsymptoms
AT gorbikovaevelina molecularpeanutsensitizationpatternsinlithuanianchildrenwithsuspectedallergicsymptoms
AT miskinytemonika molecularpeanutsensitizationpatternsinlithuanianchildrenwithsuspectedallergicsymptoms
AT eidukaiteaudrone molecularpeanutsensitizationpatternsinlithuanianchildrenwithsuspectedallergicsymptoms
AT miskinieneasta molecularpeanutsensitizationpatternsinlithuanianchildrenwithsuspectedallergicsymptoms
AT rudzevicieneodilija molecularpeanutsensitizationpatternsinlithuanianchildrenwithsuspectedallergicsymptoms